Abstract Objective To investigate the changes in the mRNA and protein expression of high-mobility group box 1 (HMGB1), Toll-like receptor 4 (TLR4), and nuclear factor-kappa B (NF-κB) in lung tissues of asthmatic mice and the interventional effect of vitamin D. Methods A total of 48 BALB/c mice were randomly divided into control group, asthma group, and 1,25-(OH)2D3 intervention group, with 16 mice in each group. An animal model of asthma was established, and lung tissue samples were taken in each group at weeks 1 and 2 of ovalbumin challenging. Conventional hematoxylin-eosin staining was used to measure airway wall thickness. Immunohistochemical staining was used to observe the expression of HMGB1, TLR4, and NF-κB in lung tissues. Quantitative real-time PCR and Western blot were used to investigate the changes in the mRNA and protein expression of HMGB1, TLR4, and NF-κB. Results At weeks 1 and 2 of ovalbumin challenging, compared with the control group, the asthma group had a significant increase in airway wall thickness and the intervention group had a significant reduction compared with the asthma group (P < 0.05). The asthma group had significantly higher mRNA expression of HMGB1, TLR4, and NF-κB in lung tissues than the control group, and the intervention group had significantly lower mRNA expression of TLR4 and NF-κB than the asthma group (P < 0.05). At week 1 of ovalbumin challenging, there was no significant difference in the mRNA expression of HMGB1 between the intervention group and the asthma group (P > 0.05). At week 2, the intervention group had a significant reduction in the mRNA expression of HMGB1 compared with the asthma group (P < 0.05). At weeks 1 and 2 of ovalbumin challenging, the asthma group had significantly higher protein expression of HMGB1, TLR4, and NF-κB in lung tissues than the control group, and the intervention group had significantly lower expression than the asthma group (P < 0.05). Airway wall thickness was positively correlated with the mRNA expression of HMGB1, TLR4, and NF-κB in lung tissues (r=0.804, 0.895, and 0.834; P < 0.05). Conclusions The HMGB1/TLR4/NF-κB signaling pathway plays an important role in the pathogenesis of asthma, and an appropriate amount of 1,25-(OH)2D3 has a regulatory effect on this pathway and may prevent the progression of asthma. Therefore, 1,25-(OH)2D3 is expected to become a new choice for the treatment of asthma.
Qiao J, Luan B, Gu H, et al. Effect of different 1,25-(OH)2D3 doses on high mobility group box1 and toll-like receptors 4 expression in lung tissue of asthmatic mice[J]. Int J Clin Exp Med, 2015, 8(3):4016-4023.
Temelkovski J, Hogan SP, Shepherd DP, et al. An improved murine model of asthma:selective airway inflammation, epithelial lesions and increased methacholine responsiveness following chronic exposure to aerosolised allergen[J]. Thorax, 1998, 53(10):849-856.
[4]
Mayuzumi H, Ohki Y, Tokuyama K, et al. Age-related difference in the persistency of allergic airway inflammation and bronchial hyperresponsiveness in a murine model of asthma[J]. Int Arch Allergy Immunol, 2007, 143(4):255-262.
[5]
Wang H, Bloom O, Zhang M, et al. HMG-1 as a late mediator of endotoxin lethality in mice[J]. Science, 1999, 285(5425):248-251.
[6]
Pugin J, Dunn I, Jolliet P, et al. Activation of human macrophages by mechanical ventilation in vitro[J]. Am J Physiol, 1998, 275(6 Pt 1):L1040-L1050.
[7]
Dumitriu IE, Baruah P, Valentinis B, et al. Release of high mobility group box1 by dendritic cells controls T cell activation via the receptor for advanced glycation end products[J]. J Immunol, 2005, 174(12):7506-7515.
[8]
Kim JH, Kim SJ, Lee IS, et al. Bacterial endotoxin induces the release of high mobility group box 1 via the IFN-beta signaling pathway[J]. J Immunol, 2009, 182(4):2458-2466.
[9]
Park JS, Arcaroli J, Yum HK. Activation of gene expression in human neutrophils by high mobility group box1 protein[J]. Am J Physiol Cell Physiol, 2003, 284(4):C870-C879.
[10]
Yang H, Hreggvidsdottir HS, Palmblad K, et al. A critical cysteine is required for HMGB1 binding to Toll-like receptor 4 and activation of macrophage cytokine release[J]. Proc Natl Acad Sci U S A, 2010, 107(26):11942-11947.
Khare D, Godbole NM, Pawar SD, et al. Calcitriol[1, 25(OH)2D3] pre-and post-treatment suppresses inflammatory response to influenza A (H1N1) infection in human lung A549 epithelial cells[J]. Eur J Nutr, 2013, 52(4):1405-1415.
[15]
Liu X, Nelson A, Wang X, et al. Vitamin D modulates prostaglandin E2 synthesis and degradation in human lung fibroblasts[J]. Am J Respir Cell Mol Biol, 2014, 50(1):40-50.
[16]
Foong RE, Shaw NC, Berry LJ, et al. Vitamin D deficiency causes airway hyperresponsiveness, increases airway smooth muscle mass, and reduces TGF-β expression in the lungs of female BALB/c mice[J]. Physiol Rep, 2014, 2(3):e00276.
Hansdottir S, Monick MM, Lovan N, et al. Vitamin D decreases respiratory syncytial virus induction of NF-kappaB-linked chemokines and cytokines in airway epithelium while maintaining the antiviral state[J]. J Immunol, 2010, 184(2):965-974.
[21]
Mitrović M, Ilić T, Stokić E, et al. Influence of glucoregulation quality on C-reactive protein, interleukin-6 and tumor necrosis factor-alpha level in patients with diabetes type 1[J]. Vojnosanit Pregl, 2011, 68(9):756-761.
[22]
Riis JL, Johansen C, Gesser B, et al. 1 alpha, 25(OH)(2)D(3) regulates NF-kappaB DNA binding activity in cultured normal human keratinocytes through an increase in IkappaB alpha expression[J]. Arch Dermatol Res, 2004, 296(5):195-202.
